triazoles has been researched along with dasatinib in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 4 (36.36) | 2.80 |
Authors | Studies |
---|---|
Scheinfeld, N | 1 |
Bovée, JV; Bruijn, IH; Hogendoorn, PC; Schrage, YM; Szuhai, K; Willems, SM | 1 |
Chakravarty, D; Challa, R; Cortez, V; Nair, BC; Tekmal, RR; Vadlamudi, RK; Vallabhaneni, S | 1 |
Craig, AW; Everingham, S; Kapur, R; Sharma, N; Zeng, LF; Zhang, ZY | 1 |
Asahina, H; Beauchamp, EM; Buczkowski, KA; Hammerman, PS; Li, YY; Meyerson, M; Terai, H; Wong, KK; Xu, C; Zhang, Y | 1 |
Bai, CG; Chen, Y; He, DD; Li, HY; Sun, TY; Zhang, Q; Zhao, XJ | 1 |
Jiao, B; Li, D; Liao, L; Liu, M; Liu, P; Ren, R; Wang, P; Xia, Z; Xiao, X; Zhang, X | 1 |
Cheng, G; Huang, L; Li, T; Luo, X; Xue, X; Zhang, Y | 1 |
Lin, G; Wang, C; Wang, Y; Wen, C; Yang, S; Zhang, X; Zhou, Z | 1 |
Brittain, SM; Henning, NJ; Manford, AG; McKenna, JM; Nomura, DK; Rape, M; Schirle, M; Spradlin, JN; Tallarico, JA; Zhang, E | 1 |
1 review(s) available for triazoles and dasatinib
Article | Year |
---|---|
A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine.
Topics: Animals; Antineoplastic Agents; Benzoates; Boronic Acids; Bortezomib; Cyclosporine; Dasatinib; Deferasirox; Humans; Iron Chelating Agents; Ophthalmic Solutions; Protein Kinase Inhibitors; Pyrazines; Pyrimidines; Randomized Controlled Trials as Topic; Skin Diseases; Skin Neoplasms; Thiazoles; Triazoles | 2007 |
10 other study(ies) available for triazoles and dasatinib
Article | Year |
---|---|
Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and casein kinase II inhibition as a potential treatment option.
Topics: Casein Kinase II; Cell Line; Cell Line, Tumor; Cell Survival; Cells, Cultured; Dasatinib; HeLa Cells; Humans; Immunoblotting; Jurkat Cells; Karyotyping; Liposarcoma, Myxoid; NF-kappa B; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Triazoles | 2010 |
Significance of ER-Src axis in hormonal therapy resistance.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Co-Repressor Proteins; Dasatinib; Drug Resistance, Neoplasm; Drug Synergism; Estrogen Receptor alpha; Female; Gene Knockdown Techniques; Humans; Letrozole; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Nitriles; Phosphorylation; Pyrimidines; Receptor, ErbB-2; RNA Interference; src-Family Kinases; Tamoxifen; Thiazoles; Transcription Factors; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |
Dasatinib-letrozole gets split verdict.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Dasatinib; Female; Humans; Letrozole; Nitriles; Protein Kinase Inhibitors; Pyrimidines; Receptor, ErbB-2; Receptors, Estrogen; Thiazoles; Treatment Outcome; Triazoles | 2014 |
Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Dasatinib; Disease Progression; Drug Synergism; Humans; Indoles; Mastocytosis, Systemic; Mice; Mice, Transgenic; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-kit; Signal Transduction; Triazoles | 2014 |
NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination Therapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Azepines; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dasatinib; Discoidin Domain Receptors; Humans; Inhibitory Concentration 50; Lung Neoplasms; Mice, Nude; Mutation, Missense; N-Myc Proto-Oncogene Protein; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Design and synthesis of novel dasatinib derivatives as inhibitors of leukemia stem cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Dasatinib; Drug Design; Drug Screening Assays, Antitumor; Humans; Leukemia; Mice; Neoplastic Stem Cells; Oxadiazoles; Triazoles | 2018 |
Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anthracenes; Antineoplastic Combined Chemotherapy Protocols; Azepines; Benzamides; Cell Line, Tumor; Dasatinib; Drug Screening Assays, Antitumor; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Neoplasm Proteins; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-myc; Pyridines; Pyrimidines; Radiation Chimera; Random Allocation; RNA Interference; RNA, Small Interfering; Signal Transduction; Triazoles | 2020 |
Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dasatinib; Drug Interactions; Drug Monitoring; Humans; Itraconazole; Ketoconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Models, Animal; Protein Kinase Inhibitors; Rats; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2020 |
Development of UPLC-MS/MS Method for Studying the Pharmacokinetic Interaction Between Dasatinib and Posaconazole in Rats.
Topics: Animals; Chromatography, High Pressure Liquid; Dasatinib; Equipment Design; Male; Molecular Structure; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Triazoles | 2021 |
Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications.
Topics: Acetamides; Animals; Azepines; Binding Sites; Carrier Proteins; Cell Cycle Proteins; Cell Line; Cysteine; Dasatinib; Fusion Proteins, bcr-abl; Humans; Mice; Proteasome Endopeptidase Complex; Protein Binding; Protein Kinase Inhibitors; Proteolysis; Recombinant Proteins; Transcription Factors; Triazoles; Ubiquitin-Protein Ligase Complexes | 2022 |